Loading company…
Vienomics, based in Shenzhen, China, develops tumor screening technology for lung cancer diagnostics and precaution.
Established in 2016 and based in Shenzhen, China, Vienomics develops tumor screening technology for lung cancer diagnostics and precaution. Its recorded funding stage is Seed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in